Sign In
Buy JNJ
$244.88
+3.88 (+1.61%)
At Close: Jun 25, 2026
Johnson & Johnson To Buy Shockwave Medical For $13.1 Billion
08:10am, Friday, 05'th Apr 2024
Johnson & Johnson will pay $13.1 billion, or $335 a share, for Shockwave Medical, which has soared in 2024 in part on takeover speculation.
Johnson & Johnson to buy Shockwave Medical for $12.5 billion
07:18am, Friday, 05'th Apr 2024
Shockwave Medical Inc (NASDAQ: SWAV) is in the green today after Johnson & Johnson (NYSE: JNJ) said it will buy the medical device maker for $12.5 billion. Shockwave Medical stock priced at a premium
Johnson & Johnson to Buy Shockwave Medical. It's a Cardio Health Play.
07:12am, Friday, 05'th Apr 2024
Johnson & Johnson is buying the medical-devices maker for a total enterprise value of about $13.1 billion.
Johnson & Johnson to acquire Shockwave Medical in $13.1 billion deal
06:40am, Friday, 05'th Apr 2024
Johnson & Johnson JNJ, -1.14% has agreed to acquire Shockwave Medical Inc. SWAV, -0.23% in an all-cash deal with an enterprise value of about $13 billion, the companies said Friday. J&J will pay $335
Johnson & Johnson to buy Shockwave Medical for $12.5 bln
06:39am, Friday, 05'th Apr 2024
Johnson & Johnson will buy medical device maker Shockwave Medical for about $12.5 billion, the companies said on Friday, helping the healthcare conglomerate boost its portfolio of medical devices.
Time to Tap Healthcare ETFs on Nvidia's AI Ambition?
08:01am, Thursday, 04'th Apr 2024
At Nvidia's last week's GTC AI conference, the company announced partnerships in the healthcare sector, representing a strategic move toward expanding its revenue streams beyond tech sectors.
Rich Returns at a Discount: 3 Dividend Aristocrats Trading at 52-Week Lows
08:48pm, Wednesday, 03'rd Apr 2024
Looking for Dividend aristocrats trading at their 52-week lows? If so, you've come to the right place.
Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?
01:16pm, Wednesday, 03'rd Apr 2024
Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Wednesday, 03'rd Apr 2024
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
12 Dividend Increases Expected In April 2024
01:40pm, Tuesday, 02'nd Apr 2024
12 expected dividend increases in April 2024. Dividend growth is crucial for reaching financial freedom and combating high inflation.
AI ETFs: Q1 of 2024 Update
09:01am, Tuesday, 02'nd Apr 2024
The year 2023 was crucial in the Artificial Intelligence (AI) industry. So far this year, we have seen Apple's efforts to join the AI race more prudently, Amazon's billion dollar investment in AI star
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
11:53am, Monday, 01'st Apr 2024
Teva Pharmaceutical and Viatris convinced a U.S. appeals court on Monday to revive their challenges to a patent covering a blockbuster Johnson & Johnson schizophrenia drug, giving them a new chance to
Procter & Gamble, Johnson & Johnson Among 10 Dividend Growth Companies Announcing Increases In First Half Of April
08:02am, Monday, 01'st Apr 2024
Procter & Gamble, Johnson & Johnson Among 10 Dividend Growth Companies Announcing Increases In First Half Of April
3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade
05:19am, Saturday, 30'th Mar 2024
Now that it's focused on just medical technology and pharmaceuticals, Johnson & Johnson's pace of annual dividend raises could accelerate. Medtronic is the largest publicly traded medical device manuf
Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock
10:06am, Friday, 29'th Mar 2024
Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.
